The effect of total intravenous anesthesia and prophylactic ramosetron on postoperative nausea and vomiting after thyroidectomy

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0001018

Enrollment

Registered

2014-03-07

Start date

2013-04-29

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : In control group, anesthesia will be induced with thiopental sodium and maintained with sevoflurane. In group TIVA + Ramo, ramosetron 0.3 mg will be intravenously administered just before the

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Euthyroid state women patients with American Society of Anesthesiologists physical status I or II, aged 20-60 years and scheduled for thyroidectomy under general anesthesia, will be enrolled.

Exclusion criteria

Exclusion criteria: Patients with more than 30% over ideal body weight, gastrointestinal disease, and those who had taken antiemetics within 24 h prior to surgery are excluded from the study.

Design outcomes

Primary

Measure	Time frame
PONV (postoperative nausea and vomiting)	—

Secondary

Measure	Time frame
Satisfaction score;Adverse events (headache, dizziness)	—

Countries

Korea, Republic of

Contacts

Public ContactHan Bum Joe

Ajou University Hospital

joehanbum@naver.com

Outcome results